Abbvie Inc
Abbvie Inc (ABBV) Wheel Strategy
ABBV wheel strategy scan found 275 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 76.9%.
Read more
Running a ABBV wheel strategy lets you generate consistent premium income on Abbvie Inc while setting your own entry and exit prices on the underlying. Abbvie Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ABBV, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ABBV wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ABBV, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ABBV wheel from a losing one.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ABBV wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ABBV wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 295.00 | $3.70 | $4.35 | -0.48 | 7 | 24% | 50.3% | 76.9% | 260 |
| Nov 20, 2026 | 292.50 | $2.73 | $3.09 | -0.39 | 7 | 24% | 59.8% | 55.1% | 37 |
| Nov 27, 2026 | 295.00 | $4.45 | $5.70 | -0.48 | 14 | 24% | 50.3% | 50.4% | 19 |
| Nov 27, 2026 | 292.50 | $3.00 | $4.43 | -0.41 | 14 | 24% | 57.0% | 39.4% | 9 |
| Nov 20, 2026 | 290.00 | $1.99 | $2.18 | -0.31 | 7 | 24% | 68.8% | 39.2% | 571 |
| Dec 4, 2026 | 295.00 | $5.40 | $6.15 | -0.47 | 21 | 24% | 50.3% | 36.2% | 0 |
| Dec 11, 2026 | 295.00 | $7.00 | $8.15 | -0.47 | 28 | 24% | 50.4% | 36.0% | 25 |
| Nov 27, 2026 | 290.00 | $2.41 | $3.61 | -0.35 | 14 | 24% | 63.6% | 32.4% | 30 |
| Dec 24, 2026 | 295.00 | $8.15 | $9.50 | -0.46 | 41 | 24% | 50.4% | 28.7% | 1 |
| Dec 31, 2026 | 295.00 | $8.55 | $10.43 | -0.46 | 48 | 24% | 50.5% | 26.9% | 0 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →